Krista Reznik, Author at JDDonline - Journal of Drugs in Dermatology

Oct 11

New Innovation for Addressing Hyperpigmentation in Diverse Patients

By Krista Reznik JDD Highlights, JDD Webinars, The Latest No Comments

Join Andrew Alexis, MD and Hawasatu Dumbuya, PhD, for an informative and interactive webinar on pigmentary disorders: unveiling insights on epidemiology, stigmatization, clinical perspectives, and a breakthrough innovation for hyperpigmentation.…

Oct 09

Love34

Formulation Foundations: A Peak Behind the Development Curtain

By Krista Reznik Dermatology Podcast Archives, Featured Podcast, JDD Highlights, Podcast Highlights No Comments

iTunes TuneIn Spotify Dr. David Osborne Finding the right formulation is not always a fun endeavor for the practitioner or patient, and can be the make or break for patient…

Oct 09

Love1

The Full Spectrum of Dermatology: A Diverse and Inclusive Atlas picture collection for drug reaction with eosinophilia and systemic symptoms, showcasing the condition in side by side multiple skin tones. Images and pictures of DRESS. Dermal, inflammatory, eosinophilic dermatology skin condition. Inclusive Derm Atlas, diversity in skin types. Skin of color included.

Decoding Derm: What’s the Diagnosis

By Krista Reznik Inclusive Dermatology Atlas, JDD Highlights, The Latest, Video Pearls

Join Dr. Alexis Carrington in Decoding Dermatology: What's the Diagnosis, as she presents a curated image collection from The Full Spectrum of Dermatology: A Diverse and Inclusive Atlas. This selection…

Oct 08

Love0

Journal of Drugs in Dermatology JDD Article About Assessing Patient Preferences for Atopic Dermatitis Treatment: A Review Article of Discrete Choice Experiments

Assessing Patient Preferences for Atopic Dermatitis Treatment: A Review Article of Discrete Choice Experiments

By Krista Reznik Featured Articles, The Latest

JDD Article Highlights Struggling with treatment adherence in your atopic dermatitis (AD) patients? AD is a widespread inflammatory skin condition, but even with various treatment options, poor adherence - especially to…

Oct 08

Love23

Technology Innovations in Skincare from Neutrogena

By Krista Reznik JDD Highlights, JDD Webinars, The Latest No Comments

Join us for a panel discussion on innovations in the technology and formulation of essential skincare from Neutrogena. Dr Ted Lain and Dr Cheri Frey will be joined by Kenvue…

Oct 07

Love0

Dermatologic Procedures for the Treatment of Seborrheic Dermatitis

By Krista Reznik Featured Articles, The Latest

Did You Miss It? Published early online in August, the JDD article titled “Dermatologic Procedures for the Treatment of Seborrheic Dermatitis” reviews alternative dermatologic procedures for treating Seborrheic Dermatitis (SD), offering clinicians…

Oct 02

Love0

The ABCs of JAKis: A Clinician’s Guide to Safety and Monitoring of the Systemic JAK Inhibitors

By Krista Reznik Featured Articles, The Latest

JDD Article Highlight Curious about the latest in dermatology treatments? Janus Kinase Inhibitors (JAKis) are gaining traction as a powerful tool for various skin conditions—but there’s more to the story.…

Oct 01

Love34

Reface the Chase: Paradigm shifts in the AD Management Strategy Mentality

By Krista Reznik Dermatology Podcast Archives, Featured Podcast, JDD Highlights, Podcast Highlights No Comments

iTunes TuneIn Spotify Dr. Raj Chovatiya Who doesn't love a good game of "Whack a Mole?" Anyone? Just as you try to stay ahead of those furry, taunting, smiling devils…

Sep 30

Love0

Journal of Drugs in Dermatology JDD article about Minimizing Medical Error-Related Adverse Events With Platelet-Rich Plasma: A Protocolized Approach to Safety

Minimizing Medical Error-Related Adverse Events With Platelet-Rich Plasma: A Protocolized Approach to Safety

By Krista Reznik Featured Articles, The Latest

JDD Article Highlight Platelet-rich concentrates (PRCs) have become popular in dermatology for a variety of treatments, but recent reports link their use to blood-borne infections like HIV and hepatitis. While…

Sep 25

Love0

Journal of Drugs in Dermatology JDD article about Cross-Sectional Analysis of Adverse Dermatologic Events Reported to the FDA After Use of GLP-1 Agonists. The most frequent reactions were rash, pruritus, and alopecia. Links to Inclusive Derm Atlas for alopecia hair related pictures.

Cross-Sectional Analysis of Adverse Dermatologic Events Reported to the FDA After Use of GLP-1 Agonists

By Krista Reznik Featured Articles, The Latest

JDD Article Highlight

Sep 23

Love0

A Clinical Histology Study Evaluating the Biostimulatory Activity Longevity of Injectable Poly-L-Lactic Acid for Facial Rejuvenation

By Krista Reznik Aesthetics, Featured Articles, The Latest

JDD Article Highlight Curious about the latest on Poly-L-lactic acid (PLLA)? Read one of JDD’s latest articles titled “A Clinical Histology Study Evaluating the Biostimulatory Activity Longevity of Injectable Poly-L-Lactic Acid…

Sep 18

Love0

Genomic Analysis Aids in the Management of Dermoscopically Atypical Pigmented Lesions

By Krista Reznik Featured Articles, The Latest

JDD Article Highlight JDD’s recent article “Genomic Analysis Aids in the Management of Dermoscopically Atypical Pigmented Lesions” evaluated whether dermoscopic features alone can reliably distinguish early melanoma in situ (MIS) from…

Krista Reznik

New Innovation for Addressing Hyperpigmentation in Diverse Patients

Formulation Foundations: A Peak Behind the Development Curtain

Decoding Derm: What’s the Diagnosis

Assessing Patient Preferences for Atopic Dermatitis Treatment: A Review Article of Discrete Choice Experiments

Technology Innovations in Skincare from Neutrogena

Dermatologic Procedures for the Treatment of Seborrheic Dermatitis

The ABCs of JAKis: A Clinician’s Guide to Safety and Monitoring of the Systemic JAK Inhibitors

Reface the Chase: Paradigm shifts in the AD Management Strategy Mentality

Minimizing Medical Error-Related Adverse Events With Platelet-Rich Plasma: A Protocolized Approach to Safety

Cross-Sectional Analysis of Adverse Dermatologic Events Reported to the FDA After Use of GLP-1 Agonists

A Clinical Histology Study Evaluating the Biostimulatory Activity Longevity of Injectable Poly-L-Lactic Acid for Facial Rejuvenation

Genomic Analysis Aids in the Management of Dermoscopically Atypical Pigmented Lesions

Advertisement

Dermatology Topics

Advertisement

Top News Stories

News Topics

Journal of Drugs in Dermatology

Search